Issued Patents All Time
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12178816 | Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one | Michael Karl Bechtold, Julie Kay Cahill, Katja Maren Fastnacht, Bernd Liepold, Claudia Bettina Packhaeuser +1 more | 2024-12-31 |
| 12144810 | Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one | Michael Karl Bechtold, Julie Kay Cahill, Katja Maren Fastnacht, Bernd Liepold, Claudia Bettina Packhaeuser +1 more | 2024-11-19 |
| 12048695 | Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one | Michael Karl Bechtold, Julie Kay Cahill, Katja Maren Fastnacht, Bernd Liepold, Claudia Bettina Packhaeuser +1 more | 2024-07-30 |
| 11975001 | Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one | Michael Karl Bechtold, Julie Kay Cahill, Katja Maren Fastnacht, Bernd Liepold, Claudia Bettina Packhaeuser +1 more | 2024-05-07 |
| 11633396 | Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one | Michael Karl Bechtold, Julie Kay Cahill, Katja Maren Fastnacht, Bernd Liepold, Claudia Bettina Packhaeuser +1 more | 2023-04-25 |
| 8735410 | Quinazoline derivatives as tyrosine kinase inhibitors | Christopher Thomas Halsall, Laurent Francois Andre Hennequin, Alleyn Thomas Plowright, Richard Anthony Storey | 2014-05-27 |
| 8475842 | Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one | Michael Karl Bechtold, Claudia Bettina Packhaeuser, Katja Maren Fastnacht, Bernd Liepold, Benedikt Steitz +1 more | 2013-07-02 |
| 8168221 | Composition 064 | John David Blyth, Andrew John Day | 2012-05-01 |